myTomorrows Enhances AI Solutions for Clinical Trials and Patient Recruitment Efforts

Improving Clinical Trials with AI

In a significant move for healthcare innovation, myTomorrows, a leading global health technology firm, is set to transform the clinical trial landscape with an advanced AI-powered solution tailored for clinical research teams. This platform aims to tackle the longstanding challenges of patient recruitment and retention that persist in clinical research, particularly during critical phase III trials.

The Challenge of Recruitment

Clinical trials face a well-documented crisis: average recruitment for phase III trials runs between 13 to 18 months, with a striking 37% of trial sites experiencing under-enrollment. Moreover, a significant portion of physicians—72%—express frustration regarding the excessive time required for searching and pre-screening potential trial candidates. Adding further complexity, outdated public trial registries often perpetuate unsuitable patient referrals, leading to inefficiencies and wasted time.

Introducing the New Solution

To address these issues, myTomorrows expands its proprietary AI trial matching platform. This new referral management tool consolidates both internal and external referrals in a single, comprehensive interface, ensuring not only real-time trial updates but also streamlined workflows that reduce burdens on clinical sites. This significant enhancement allows medical teams to pre-screen patients more effectively and enhances overall recruitment efficiency.

This integrated approach offers a dual benefit: it enhances trial visibility and actively facilitates the expansion of referral networks among clinical sites. Unlike traditional registries that rely on static information, this platform empowers sites to dynamically add and modify trial details, making it easier for physicians to receive timely updates and clarifications regarding recruitment needs.

Elevating Communication

A key feature of the new platform is its ability to improve communication between clinical teams and referring physicians. By allowing direct messaging capabilities, the platform ensures that physician inquiries are promptly addressed, while referring doctors can efficiently pre-screen their patients using AI tools. This builds a more high-touch communication environment that benefits all stakeholders involved.

AI Capabilities and Accuracy

myTomorrows claims to have developed the most accurate LLM-enabled platform for trial matching and screening, promising up to 98% eligibility accuracy. The platform utilizes advanced algorithms to assess patient data, such as prior treatments and genetic markers, swiftly determining suitability for ongoing trials. Furthermore, integration options with electronic health records (EHRs) enable automated, large-scale screening processes, accelerating patient matching beyond the scope of traditional methods.

The security and privacy of this new system are paramount, with the framework designed to meet GDPR, HIPAA, ISO 27001, and SOC 2 standards, ensuring compliance with international regulations.

The Impact of Early Adoption

Early adopters of this innovative platform have reported increased enrollment acceptance rates and marked improvements in recruitment times, promising to enhance the productivity of clinical trial sites significantly. Alongside these technological advancements, myTomorrows maintains a dedicated team of community managers and patient navigators who have collectively supported over 16,200 patients and 2,600 physicians internationally, reinforcing the company's commitment to improving the patient experience.

Commitment to Equitable Access

At the forefront of its mission, myTomorrows expresses a desire to eradicate the barriers preventing equitable patient access to clinical trials. According to CEO Michel van Harten, by combining cutting-edge AI with dedicated human support, the company aims to facilitate a more efficient recruitment process, thus elevating the overall quality of patient experience and engagement throughout their clinical journey.

In conclusion, myTomorrows leverages its innovative AI to significantly reshape the ways in which clinical trials operate, empowering sites, enhancing physician collaboration, and ensuring optimal patient engagement. As the healthcare landscape continues to evolve, myTomorrows remains dedicated to refining its offerings to meet the diverse needs of the ever-changing pre-approval ecosystem. For further information and to explore how myTomorrows can optimize site referral management, visit their official website today.